Multi-stakeholder digital strategy purpose-built for life sciences environments. Oliven Labs maps distinct journeys across patients, providers, payers (Medicare, Medicaid, and commercial), regulators, and internal commercial teams — surfacing the cross-cutting decisions that align cross-functional execution and accelerate commercial uptake, grounded in the Oliven Labs Manifesto on responsible AI in healthcare.
Patient-facing clinical and commercial experiences, provider-facing tools for diagnostics workflows, biotech patient programs, and pharma HCP enablement. Oliven Labs builds the life sciences digital experiences that drive clinical adoption, commercial uptake, and patient engagement across the diagnostics, biotech, and pharma lifecycle, including our work to rebuild executive trust at a life sciences company through visible UX progress.
FDA, HIPAA, CMS, HITRUST, and WCAG 2.1 AA-aligned product design and engineering from day one. Every life sciences workflow, data flow, and interface element is architected with traceable compliance documentation — built to pass regulatory and procurement cycles on the first attempt.
Integrate real-world evidence, clinical trial data, claims data across Medicare, Medicaid, and commercial markets, and commercial analytics into unified life sciences digital experiences. Oliven Labs builds the data integration layer that connects life sciences insight across clinical, commercial, and regulatory contexts — the foundation behind our Medicare-adjacent diagnostics analytics platform.
Proprietary AI-powered interactive journey mapping for life sciences digital products — a living cross-functional reference with embedded opportunities and future-state scenarios purpose-built for multi-stakeholder life sciences ecosystems spanning diagnostics, biotech, and pharma.
Ship first-to-market life sciences platforms with embedded compliance from day one — proven against fixed-window FDA timelines, payer procurement cycles, and commercial launch dates that traditional life sciences operating models often miss. Oliven Labs has delivered 6X faster time-to-delivery than industry norms, see how we did it through embedded product leadership accelerating healthcare innovation.
Our proprietary methodology turns life sciences digital ambition into market-ready products that win regulators, commercial buyers, and patients across diagnostics, biotech, and pharma. We deliver through expert specialists, milestone-driven frameworks, and custom AI products built to accelerate outcomes.
Life sciences digital experiences built for the real ecosystem — patients, providers, payers across Medicare, Medicaid, and commercial markets — each anchored to the specific decisions and workflows they navigate.
Real-world evidence, clinical data, claims integration across operational data unified into AI-powered decision intelligence platforms — purpose-built for FDA, HIPAA, and HITRUST-regulated life sciences environments and accelerated time-to-market.
An integrated expert team spanning UX strategy, clinical fluency, regulatory design, data engineering, product management, and engineering — built to ship life sciences digital products into FDA and HIPAA-regulated environments at the speed diagnostics, biotech, and pharma require. End-to-end delivery from a single team.
50+ years of deep life sciences and healthcare expertise — HIPAA, CMS, FDA, HITRUST, and WCAG 2.1 AA-aligned, proven across cancer screening, molecular diagnostics, biotech digital products, pharma HCP enablement, and payer-facing experiences across Medicare, Medicaid, and commercial markets.
Ground-up development of a revolutionary analytics tool that provides continuous plan monitoring and optimization for agents and seniors unlike any product in the industry.
Rebuilding executive trust through rapid, visible UX progress while delivering compliant, scalable healthcare solutions at speed.
Transforming industry-leading risk management software where many others failed—empowering thousands of healthcare workers, speeding deployment by 5x, and driving substantial revenue growth.